I agree that this site is using cookies. You can find further informations here.
X
Rik J. Verheijden
37  results:
Search for persons X
?
1

A prediction model for response to immune checkpoint inhibi..:

van Duin, Isabella A. J. ; Verheijden, Rik J. ; van Diest, Paul J....
International Journal of Cancer.  154 (2024)  10 - p. 1760-1771 , 2024
Link: https://doi.org/10.1002/..
 
?
2

In vitro T cell responses to PD-1 blockade are reduced by I..:

Timmerman, Laura M. ; Hensen, Lobke C. M. ; van Eijs, Mick J. M....
Cancer Immunology, Immunotherapy.  73 (2024)  9 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
3

BRAF/MEK inhibitor rechallenge in advanced melanoma patient:

Van Not, Olivier J. ; van den Eertwegh, Alfons J. M. ; Haanen, John B....
Cancer.  130 (2024)  9 - p. 1673-1683 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Corticosteroids and other immunosuppressants for immune-rel..:

Verheijden, Rik J. ; Burgers, Femke H. ; Janssen, Josephine C....
European Journal of Cancer.  207 (2024)  - p. 114172 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Prognostic value of Lynch syndrome, BRAFV600E, and RAS muta..:

Zwart, Koen ; van der Baan, Frederieke H. ; Cohen, Romain...
Cancer Medicine.  12 (2023)  15 - p. 15841-15853 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Time interval from primary melanoma to first distant recurr..:

van Duin, Isabella A. J. ; Elias, Sjoerd G. ; van den Eertwegh, Alfonsus J. M....
International Journal of Cancer.  152 (2023)  12 - p. 2493-2502 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Physical activity and checkpoint inhibition: association wi..:

Verheijden, Rik J ; Cabané Ballester, Anna ; Smit, Karel C...
JNCI: Journal of the National Cancer Institute.  116 (2023)  4 - p. 573-579 , 2023
Link: https://doi.org/10.1093/..
 
?
8

Immunosuppression for immune-related adverse events during ..:

Verheijden, Rik J. ; van Eijs, Mick J. M. ; May, Anne M...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

Toxicity-specific peripheral blood T and B cell dynamics in..:

van Eijs, Mick J. M. ; Verheijden, Rik J. ; van der Wees, Stefanie A....
Cancer Immunology, Immunotherapy.  72 (2023)  12 - p. 4049-4064 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Highly multiplexed spatial analysis identifies tissue-resid..:

van Eijs, Mick J.M. ; ter Linde, José J.M. ; Baars, Matthijs J.D....
iScience.  26 (2023)  10 - p. 107891 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Frailty and checkpoint inhibitor toxicity in older patients..:

Bruijnen, Cheryl P. ; Koldenhof, José J. ; Verheijden, Rik J....
Cancer.  128 (2022)  14 - p. 2746-2752 , 2022
Link: https://doi.org/10.1002/..
 
?
12

Patient-Reported Outcomes During Checkpoint Inhibition: Ins..:

Koldenhof, Josephine J. ; van der Baan, Frederieke H. ; Verberne, Elisabeth G....
Journal of Pain and Symptom Management.  63 (2022)  6 - p. 997-1005 , 2022
Link: https://doi.org/10.1016/..
 
?
13

TNF inhibition for immune checkpoint inhibitor-induced irAE..:

Suijkerbuijk, Karijn P. M. ; Verheijden, Rik J.
Nature Reviews Rheumatology.  17 (2021)  8 - p. 505-505 , 2021
Link: https://doi.org/10.1038/..
 
?
14

Biomarkers of Checkpoint Inhibitor Induced Immune-Related A..:

Hommes, Josefien W. ; Verheijden, Rik J. ; Suijkerbuijk, Karijn P. M..
Frontiers in Oncology.  10 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Lower risk of severe checkpoint inhibitor toxicity in more ..:

Verheijden, Rik J. ; May, Anne M. ; Blank, Christian U....
ESMO Open.  5 (2020)  6 - p. e000945 , 2020
Link: https://doi.org/10.1136/..
 
1-15